Stereotaxis, Inc. (STXS)Healthcare | Medical Instruments & Supplies | Saint Louis, United States | NYSE American
1.05 USD
-0.01
(-0.943%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 1:31 a.m. EDT
The immediate outlook is severely clouded by deteriorating fundamentals and a complete lack of income generation. The company is burning cash aggressively, with operating cash flow and free cash flow both deeply negative, while revenue has contracted by nearly 13%. The balance sheet shows significant distress, with debt-to-equity nearing 30 and negative returns on both assets and equity, signaling that the business model is currently failing to generate capital. While the long-term price trajectory over the last nine years remains positive due to a massive rally in 2019 and a recovery in 2025, the most recent annual performance was flat, and the current operational reality suggests the previous growth era may have stalled. There is no dividend to provide a floor, and the stock trades at a premium to book value despite earning nothing. On the short end, the technical picture is grim, with the price trading well below its 50-day and 200-day moving averages, confirming a downtrend. The options market reflects this pessimism, with heavy put positioning in the medium term and virtually no call activity. This is a speculative turnaround play with high execution risk and no current financial support. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.064976 |
| MSTL | 0.067787 |
| AutoTheta | 0.229050 |
| AutoARIMA | 0.272700 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 0.21 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.419 |
| Excess Kurtosis | -0.82 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 29.599 |
| Revenue per Share | 0.311 |
| Market Cap | 105,212,280 |
| Forward P/E | -6.77 |
| Beta | 1.37 |
| Profit Margins | -74.24% |
| Website | https://www.stereotaxis.com |
As of Oct. 10, 2026, 1:31 a.m. EDT: Speculators are overwhelmingly bearish, with significant put volume concentrated in February 2027 expirations while call activity remains negligible. Implied volatility is effectively zero for puts, indicating a lack of hedging demand or fear of a sudden spike, whereas call IV is elevated relative to put IV, suggesting speculative interest is limited to very distant, low-probability upside scenarios rather than near-term catalysts.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6534654 |
| Address1 | 710 North Tucker Boulevard |
| Address2 | Suite 110 |
| All Time High | 154.0146 |
| All Time Low | 0.47 |
| Ask | 0.0 |
| Ask Size | 2,600 |
| Audit Risk | 9 |
| Average Daily Volume10 Day | 582,130 |
| Average Daily Volume3 Month | 808,118 |
| Average Volume | 808,118 |
| Average Volume10Days | 582,130 |
| Beta | 1.366 |
| Bid | 0.0 |
| Bid Size | 27,100 |
| Board Risk | 7 |
| Book Value | 0.125 |
| City | Saint Louis |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.05 |
| Current Ratio | 1.418 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.05 |
| Day Low | 1.03 |
| Debt To Equity | 29.599 |
| Display Name | Stereotaxis |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,480,200 |
| Earnings Call Timestamp Start | 1,786,480,200 |
| Earnings Timestamp | 1,786,478,400 |
| Earnings Timestamp End | 1,794,859,200 |
| Earnings Timestamp Start | 1,794,859,200 |
| Ebitda | -18,058,000 |
| Ebitda Margins | -0.60056996 |
| Enterprise To Ebitda | -5.822 |
| Enterprise To Revenue | 3.496 |
| Enterprise Value | 105,128,288 |
| Eps Current Year | -0.21 |
| Eps Forward | -0.155 |
| Eps Trailing Twelve Months | -0.24 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.3182 |
| Fifty Day Average Change | -0.26820004 |
| Fifty Day Average Change Percent | -0.2034593 |
| Fifty Two Week Change Percent | -65.34654 |
| Fifty Two Week High | 3.19 |
| Fifty Two Week High Change | -2.14 |
| Fifty Two Week High Change Percent | -0.6708464 |
| Fifty Two Week Low | 1.03 |
| Fifty Two Week Low Change | 0.01999998 |
| Fifty Two Week Low Change Percent | 0.019417457 |
| Fifty Two Week Range | 1.03 - 3.19 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,092,317,400,000 |
| Float Shares | 65,540,241 |
| Forward Eps | -0.155 |
| Forward P E | -6.7741933 |
| Free Cashflow | -8,830,500 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 131 |
| Fullday Change | -0.00999999 |
| Fullday Change Percent | -0.9615376 |
| Fullday Price | 1.03 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.55567 |
| Gross Profits | 16,708,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15205 |
| Held Percent Institutions | 0.49716 |
| Implied Shares Outstanding | 100,202,178 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,383,523,200 |
| Last Split Factor | 1,096:1000 |
| Long Business Summary | Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. |
| Long Name | Stereotaxis, Inc. |
| Market | us_market |
| Market Cap | 105,212,280 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_34778 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -23,587,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 140,283,049 |
| Number Of Analyst Opinions | 3 |
| Open | 1.04 |
| Operating Cashflow | -15,290,000 |
| Operating Margins | -0.59556997 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.31 |
| Phone | 314 678 6100 |
| Pre Market Change | -0.00999999 |
| Pre Market Change Percent | -0.9615376 |
| Pre Market Price | 1.03 |
| Pre Market Time | 1,792,061,101 |
| Previous Close | 1.06 |
| Price Eps Current Year | -5.0 |
| Price Hint | 4 |
| Price To Book | 8.4 |
| Price To Sales Trailing12 Months | 3.4991446 |
| Profit Margins | -0.74241996 |
| Quick Ratio | 0.909 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.943395 |
| Regular Market Day High | 1.05 |
| Regular Market Day Low | 1.03 |
| Regular Market Day Range | 1.03 - 1.05 |
| Regular Market Open | 1.04 |
| Regular Market Previous Close | 1.06 |
| Regular Market Price | 1.05 |
| Regular Market Time | 1,792,008,000 |
| Regular Market Volume | 692,242 |
| Return On Assets | -0.25379 |
| Return On Equity | -1.84267 |
| Revenue Growth | -0.128 |
| Revenue Per Share | 0.311 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 100,202,178 |
| Shares Percent Shares Out | 0.056700002 |
| Shares Short | 5,681,816 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 5,052,099 |
| Short Name | Stereotaxis, Inc. |
| Short Percent Of Float | 0.067 |
| Short Ratio | 10.85 |
| Source Interval | 15 |
| State | MO |
| Symbol | STXS |
| Target High Price | 3.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 3.0 |
| Target Median Price | 3.0 |
| Total Cash | 10,491,000 |
| Total Cash Per Share | 0.105 |
| Total Debt | 5,173,000 |
| Total Revenue | 30,068,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.24 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.7993 |
| Two Hundred Day Average Change | -0.7493 |
| Two Hundred Day Average Change Percent | -0.41643974 |
| Type Disp | Equity |
| Volume | 692,242 |
| Website | https://www.stereotaxis.com |
| Zip | 63,101 |